-
EP2970430
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2970430
| EP2970430 - RECOMBINANT FACTOR VIII FORMULATIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.09.2019 Database last updated on 03.09.2024 | |
| Former | Examination is in progress Status updated on 21.12.2018 | Most recent event Tooltip | 13.09.2019 | Application deemed to be withdrawn | published on 16.10.2019 [2019/42] | Applicant(s) | For all designated states Bayer HealthCare LLC 100 Bayer Boulevard Whippany, NJ 07981-0915 / US | [2016/03] | Inventor(s) | 01 /
WANG, De Qian 4400 Water Oak Court Concord California 94521 / US | 02 /
MA, Xinghang 2511 Valentine Drive Dublin California 94568 / US | 03 /
TSVETKOVA, Nelly 7305 Hapsburg Crown Court Vallejo California 94591 / US | [2016/03] | Representative(s) | BIP Patents c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 50 40789 Monheim am Rhein / DE | [N/P] |
| Former [2016/03] | BIP Patents c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 10 40789 Monheim am Rhein / DE | Application number, filing date | 14770228.6 | 11.03.2014 | [2016/03] | WO2014US23357 | Priority number, date | US201361799495P | 15.03.2013 Original published format: US 201361799495 P | US201361869191P | 23.08.2013 Original published format: US 201361869191 P | [2016/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014150477 | Date: | 25.09.2014 | Language: | EN | [2014/39] | Type: | A1 Application with search report | No.: | EP2970430 | Date: | 20.01.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.09.2014 takes the place of the publication of the European patent application. | [2016/03] | Search report(s) | International search report - published on: | US | 25.09.2014 | (Supplementary) European search report - dispatched on: | EP | 09.12.2016 | Classification | IPC: | C07K14/755, A61K38/37, A61P7/04 | [2016/03] | CPC: |
A61K38/37 (EP,US);
A61K47/02 (US);
A61K47/22 (US);
A61K47/60 (EP,US);
A61P7/04 (EP);
C07K14/755 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/03] | Extension states | BA | 15.10.2015 | ME | 15.10.2015 | Title | German: | FORMULIERUNGEN DES REKOMBINANTEN FAKTORS VIII | [2016/03] | English: | RECOMBINANT FACTOR VIII FORMULATIONS | [2016/03] | French: | FORMULATIONS DE FACTEUR VIII RECOMBINANT | [2016/03] | Entry into regional phase | 15.10.2015 | National basic fee paid | 15.10.2015 | Search fee paid | 15.10.2015 | Designation fee(s) paid | 15.10.2015 | Examination fee paid | Examination procedure | 15.01.2015 | Request for preliminary examination filed International Preliminary Examining Authority: US | 15.10.2015 | Examination requested [2016/03] | 30.06.2017 | Amendment by applicant (claims and/or description) | 02.01.2019 | Despatch of a communication from the examining division (Time limit: M04) | 14.05.2019 | Application deemed to be withdrawn, date of legal effect [2019/42] | 07.06.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/42] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.01.2019 | Fees paid | Renewal fee | 31.03.2016 | Renewal fee patent year 03 | 10.03.2017 | Renewal fee patent year 04 | 13.03.2018 | Renewal fee patent year 05 | 01.04.2019 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO0048635 (BESMAN MARC [US], et al) [Y] 1-7 *cf.abstract, page 4, last para. bridging with line 13 at page 5, page 7, lines 7-20, claims 1-3, 6 and 34*; | [IY]WO2010054238 (BAXTER INT [US], et al) [I] 3-6 *cf. abstract, sections [0013] to [0020] at pages 4 and 5, page 9, section [0040], section [0044] at page 10, section [0091] at page 26, sections [00145] and [00146] at page 46, claims 1-6 and 11* [Y] 1,2,7; | [IY]EP0818204 (BAYER AG [US]) [I] 3-6 *cf. abstract, claims* [Y] 1,2,7; | [Y]WO0046835 (NIPPON ELECTRIC GLASS CO [JP], et al) [Y] 1-7 *cf. abstract, page 4, line 20 bridging with line 29 of page 5, page 6, lines 1-10, page 7, lines 10-24, page 10, 2nd para., page 11, 2nd para.,table 11 at page 29, claims 1-3* | International search | [X]US2012121613 (TANG LIANG [US], et al); | [X]US2012083446 (BESMAN MARC [US], et al); | [Y]US5763401 (NAYAR RAJIV [US]); | [Y]US2005256038 (WHITE MARY [GB], et al); | [Y]US2007244301 (SIEKMANN JUERGEN [AT], et al); | [A] - LIND ET AL., "Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.", EUR. J. BIOCHEM, (19950815), vol. 232, no. 1, pages 19 - 27, XP002111900 DOI: http://dx.doi.org/10.1111/j.1432-1033.1995.tb20776.x |